Orca Bio, Inc.

About Orca Bio, Inc.

Orca Bio is a clinical-stage cell therapy company developing high-precision allogeneic stem cell and T-cell therapeutics to treat blood cancers, genetic disorders and autoimmune diseases. Its proprietary Orca-Q platform enables precise purification and formulation of donor-derived cell subsets to reduce graft-versus-host disease and improve engraftment outcomes. The company is advancing multiple Phase 2/3 trials in hematopoietic stem cell transplantation and has partnerships with leading transplant centers to commercialize next-generation cellular medicines.